Nu-Med Plus (NUMD) Operating Leases (2019 - 2022)
Nu-Med Plus' (NUMD) quarterly Operating Leases came in at $2056.0 in Q2 2022, up 3.06% year-over-year from $1995.0 in Q2 2021, and down 59.98% quarter-over-quarter from $5138.0 in Q1 2022.
Analysis
Nu-Med Plus (NUMD) Operating Leases (2019 - 2022) Analysis & Trends
Nu-Med Plus has disclosed Operating Leases across 4 years of filings, most recently posting $2056.0 for Q2 2022.
- In Q2 2022, Operating Leases rose 3.06% year-over-year to $2056.0; the TTM figure through Jun 2022 stood at $2056.0 (up 3.06% YoY), while the FY2021 annual figure was $8222.0, up 3.02% from the prior year.
- Operating Leases came in at $2056.0 for Q2 2022 at Nu-Med Plus, down from $5138.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $11647.0 in Q3 2021 to a low of $1995.0 in Q2 2021.
- Average Operating Leases over 4 years is $6242.2, with a median of $5255.0 recorded in 2020.
- Year-over-year, Operating Leases grew 6.61% in 2020 and retreated 7.15% in 2021.
- Over 4 years, Operating Leases stood at $8396.0 in 2019, then retreated by 4.94% to $7981.0 in 2020, then rose by 3.02% to $8222.0 in 2021, then plunged by 74.99% to $2056.0 in 2022.
- Per Business Quant data, the three most recent Operating Leases figures were $2056.0 in Q2 2022, $5138.0 in Q1 2022, and $8222.0 in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 2,056.00 |
| Mar 31, 2022 | 5,138.00 |
| Dec 31, 2021 | 8,222.00 |
| Sep 30, 2021 | 11,647.00 |
| Jun 30, 2021 | 1,995.00 |
| Mar 31, 2021 | 4,988.00 |
| Dec 31, 2020 | 7,981.00 |
| Sep 30, 2020 | 10,975.00 |
| Jun 30, 2020 | 2,148.00 |
| Mar 31, 2020 | 5,372.00 |
| Dec 31, 2019 | 8,396.00 |
| Sep 30, 2019 | 11,418.00 |
| Jun 30, 2019 | 2,016.00 |
| Mar 31, 2019 | 5,039.00 |